Antimicrobial peptides in inflammatory phenotypes of COPD

Antimicrobial peptides in inflammatory phenotypes of COPD

Bibliographic Details
Main Authors:	Cane, J, Thulborn, S, Piper, S, Finch, D, Bafadhel, M
Format:	Conference item
Published:	BMJ Publishing Group 2017

Similar Items

Case series of long-term macrolide therapy effect on eosinophil count in COPD
by: Asciak, R, et al.
Published: (2017)

Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
by: Hambleton, K, et al.
Published: (2016)

The effect of corticosteroids on internalisation of non-typeable Haemophilus influenzae into epithelial cells
by: Cane, J, et al.
Published: (2017)

Glucocorticoid receptor α and β expression in bronchial epithelial cells infected with NTHi
by: Parker, L, et al.
Published: (2017)

Neutrophil elastase as a biomarker for bacterial infection in COPD
by: Thulborn, S, et al.
Published: (2019)

Eosinophil migration is enhanced towards IL-5 and eotaxin in COPD
by: Lababidi, R, et al.
Published: (2017)

Free-living Haemophilus Influenzae is associated with increased pulmonary inflammation
by: Thulborn, S, et al.
Published: (2015)

Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO
by: Camp, J, et al.
Published: (2018)

Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD.
by: Thulborn, S, et al.
Published: (2017)

Cell-dissociated haemophilus influenzae and bacteria-associated inflammatory mediators in the airways of patients with chronic obstructive pulmonary disease
by: Thulborn, SJ, et al.
Published: (2017)

Neutrophil elastase as a biomarker for bacterial infection in COPD
by: Samantha J. Thulborn, et al.
Published: (2019-07-01)

Identification of viable and non-viable haemophilus influenzae using qPCR
by: Thulborn, S, et al.
Published: (2016)

The role of CT scanning in multidimensional phenotyping of COPD.
by: Bafadhel, M, et al.
Published: (2011)

Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD
by: Thulborn SJ, et al.
Published: (2017-04-01)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
by: James Camp, et al.
Published: (2018-09-01)

S45 Evaluating the sensitivity and specificity of active neutrophil elastase as a biomarker for bacterial infection in subjects with copd
by: Thulborn, SJ, et al.
Published: (2016)

Evaluating the sensitivity and specificity of Neatstik® technology compared to an activity-based immunoassay in sputum samples
by: Thulborn, S, et al.
Published: (2018)

Biomarkers in COPD
by: Ramakrishnan, S, et al.
Published: (2021)

Antimicrobial and Antibiofilm Peptides
by: Angela Di Somma, et al.
Published: (2020-04-01)

Symptomatic COPD: is it time for triple therapy?
by: Bafadhel, M
Published: (2018)

Clinical and inflammatory characteristics of patients with COPD in primary care: an observational study
by: Davies, J, et al.
Published: (2017)

Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations
by: Jie Gao, et al.
Published: (2020-02-01)

Are COPD and cardiovascular disease fundamentally intertwined?
by: Bafadhel, M, et al.
Published: (2016)

What will happen in the world of COPD 2030?
by: Russell, REK, et al.
Published: (2019)

Identification of pulmonary treatable traits in a real-life setting
by: Simpson, J, et al.
Published: (2018)

Is it time to give up on "self-management" of COPD exacerbations?
by: Ramakrishnan, S, et al.
Published: (2020)

Detection of cell-dissociated non-typeable haemophilus influenzae in the airways of patients with chronic obstructive pulmonary disease
by: Thulborn, SJ, et al.
Published: (2020)

Detection of Cell-Dissociated Non-Typeable Haemophilus influenzae in the Airways of Patients with Chronic Obstructive Pulmonary Disease
by: Thulborn SJ, et al.
Published: (2020-06-01)

Inhaled glucocorticoids and COPD exacerbations.
by: Brightling, C, et al.
Published: (2015)

Effect of corticosteroids on epithelial cell response to non-typeable haemophilus influenzae
by: Cane, J, et al.
Published: (2016)

Mechanism of Antimicrobial Peptides: Antimicrobial, Anti-Inflammatory and Antibiofilm Activities
by: Ying Luo, et al.
Published: (2021-10-01)

Role of aberrant metalloproteinase activity in the pro-inflammatory phenotype of bronchial epithelium in COPD
by: Postma Dirkje S, et al.
Published: (2011-08-01)

Investigating blood eosinophil count thresholds in patients with COPD
by: Russell, R, et al.
Published: (2018)

Eosinophils in COPD: just another biomarker?
by: Bafadhel, M, et al.
Published: (2017)

Characterising non-eosinophilic COPD
by: Hambleton, K, et al.
Published: (2015)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
by: Shrimanker, R, et al.
Published: (2017)

A patient evaluation of performing COPD research in primary care
by: Jeffers, H, et al.
Published: (2017)

S14 Eosinophil activation status and CD62L expression in airways disease
by: Cane, J, et al.
Published: (2018)

COPD phenotypes: differences in survival
by: Hernández Vázquez J, et al.
Published: (2018-07-01)

Recent advances in the field of antimicrobial peptides in inflammatory diseases
by: Patricia Méndez-Samperio
Published: (2013-01-01)